Can a seizure drug help obese kids lose weight?
NCT ID NCT02273804
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tested whether topiramate, a drug usually used for seizures, can help severely obese children and teenagers lose weight. 18 participants aged 9 to 17 took either topiramate or a placebo for 9 months. The main goal was to see if the drug could lower their Body Mass Index (BMI) more than a placebo.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OBESE CHILDREN AND ADOLESCENTS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Hopital Bicêtre
Le Kremlin-Bicêtre, Paris, 94275, France
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Will shedding pounds heal the pancreas? MRI scans seek answers
- Can a second bypass surgery rescue failed weight loss?
- MRI reveals how weight loss drugs reshape organs in severely obese teens
- Weight loss surgery may shield kidneys in obese patients
- Exercise boosts benefits of Weight-Loss surgery, study finds
- Bariatric Surgery's lasting impact under the microscope after a decade